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SUMMARY
Pseudouridine is the most abundant RNA modification, yet except for a few well-studied cases,
little is known about the modified positions and their function(s). Here, we develop Ψ-seq for
transcriptome-wide quantitative mapping of pseudouridine. We validate Ψ-seq with spike-ins and
de novo identification of previously reported positions and discover hundreds of novel sites in
human and yeast mRNAs and snoRNAs. Perturbing pseudouridine synthases (PUSs) uncovers
which PUSs modify each site and their target sequence features. mRNA pseudouridinylation
depends on both site-specific and snoRNA-guided PUSs. Upon heat shock in yeast, Pus7-
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mediated pseudouridylation is induced at >200 sites and Pus7 deletion decreases the levels of
otherwise pseudouridylated mRNA, suggesting a role in enhancing transcript stability. rRNA
pseudouridine stoichiometries are conserved, but reduced in cells from dyskeratosis congenita
patients, where the PUS DKC1 is mutated. Our work identifies an enhanced, transcritome-wide
scope for pseudouridine, and methods to dissect its underlying mechanisms and function.
Introduction
The most abundant RNA modification is pseudouridine (Ψ). In yeast, Ψ is present in many
positions in tRNAs, in 46 positions across the four rRNAs (25S, 18S, 5.8S, 5S), and in 6
positions in U1, U2 and U5 snRNA (Charette and Gray, 2000; Ofengand, 2002; Yu et al.,
2011). Although ψ’s base pairing is similar to uridine, isomerization allows the potential
formation of an extra hydrogen bond, and may contribute to structural stability (Durant and
Davis, 1997; Kierzek et al., 2014). Pseudouridine is catalyzed by pseudouridine synthases
(PUSs). In yeast, 8 non-essential PUSs directly catalyze ψ formation at specific sites in
tRNA, U2 snRNA and mitochondrial rRNA (Ansmant et al., 2000; Behm-Ansmant et al.,
2003; Massenet et al., 1999). In contrast, all positions in rRNA and one position in U2
snRNA are modified by the essential PUS Cbf5, which is guided to its target positions
through H/ACA-box snoRNAs, based on a 10–12 nt stretch of complementarity to the
sequence spanning the target (Lafontaine et al., 1998; Watkins et al., 1998). In human, 23
proteins harbor a PUS domain (Hunter et al., 2011), but most have not been studied for
function or specificity.
Although the roles of individual Ψ modifications have largely remained elusive,
pseudouridylation defects have profound effects. Alteration of bacterial rRNA
pseudouridylation affects antibiotic sensitivity (Toh and Mankin, 2008), ablation of rRNA
pseudouridylation by CBF5 deletion in S. cerevisae is lethal (Jiang et al., 1993; Zebarjadian
et al., 1999), and defects in DKC1/Dyskerin, the mammalian CBF5 ortholog, cause
dyskeratosis congenita (Heiss et al., 1998), a disorder characterized by failure of ribosome
biogenesis and an increased risk of cancer (Hoareau-Aveilla et al., 2008). Furthermore,
deletion of S. cerevisiae PUS1 results in growth defects, and mutation of human PUS1 leads
to mitochondrial myopathy and sideroblastic anemia (Fujiwara and Harigae, 2013).
Recent findings that a few Ψ sites in yeast U2 snRNA are induced by nutrient deprivation or
heat shock (Wu et al., 2011) and rRNA sites by rapamycin treatment (Courtes et al., 2014)
raise the possibility that the pseudouridine landscape may be more complex and dynamic
than previously assumed, and that Ψ might also be present in other RNA species, including
mRNA. Testing this hypothesis requires a sensitive method for transcriptome-wide mapping
of Ψ sites. Such an assay would also permit identification of the enzyme(s) that catalyze the
modification at each site and their specificity, as well as an assessment of whether Ψ is a
dynamic feature.
Here, we develop Ψ-seq, for transcriptome-wide quantitative mapping of Ψ, and use it to
identify the vast majority of previously reported sites in rRNA, tRNA and snRNA and
dozens of novel sites within snoRNAs and mRNAs. Combining Ψ-seq with genetic
perturbations, we associate each site with its cognate PUS and/or snoRNA, finding that
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mRNA Ψ sites are mediated by at least 4 different PUSs, conserved from yeast to mammals.
Hundreds of sites are induced by heat shock in yeast, in a Pus7-dependent manner, possibly
affecting transcript stability. Finally, we find subtle, but significant, decrease in rRNA and
TERC pseudouridylation in cells from patients with dyskeratosis congenita. Our results
establish show that Ψ is ubiquitous in diverse RNAs, and dynamic in mRNA, and provide a
transcriptome-wide assay for functional studies.
Results
Transcriptome-wide mapping of pseudouridine with Ψ-seq
To map Ψ across the transcriptome we developed Ψ-seq, relying on the unique stability of
N3-[N-cyclohexyl-N′-β-(4-methylmorpholinium)ethylcarbodiimide-Ψ (N3-CMC-Ψ) to
alkaline hydrolysis, and the ability of N3-CMC-Ψ to terminate reverse transcription. This
was previously used to test individual sites in primer-extension assays (Bakin and Ofengand,
1993, 1995; Bakin and Ofengand, 1998). Here, we coupled it with strand-specific RNA-seq.
Specifically (Figure 1A), we (1) treat polyA-selected RNA with CMC, which covalently
binds to U, G and Ψ residues (Ho and Gilham, 1971; Metz and Brown, 1969a, b); (2)
incubate CMC-treated RNA at alkaline pH, leading to hydrolysis of the less stable U-CMC
and G-CMC adducts; (3) fragment RNA (to 80–150 nt), ligate 3′ adapter and reverse
transcribe, expecting premature termination at Ψ-CMC sites; and (4) ligate an adapter to the
3′ end of the cDNA, followed by library preparation. For each experiment, we sequenced
both a treated sample and input RNA that was not treated with CMC, but otherwise handled
identically (Experimental Procedures).
We defined two metrics to analyze Ψ-seq data (Figure 1B). The Ψ-ratio is the proportion of
reads supporting reverse transcription termination at a position out of all the reads
overlapping it. The Ψ-fold-change (Ψ-fc) is the log2 transformed Ψ-ratio in the treated
samples divided by the Ψ-ratio in the non-treated (input) samples. This controls for non-
uniform coverage in RNA-seq due to mappability gaps or complex RNA processing.
We confirmed Ψ-seq’s ability to identify Ψ sites and quantify their relative stoichiometry, by
spiking into a complex sample a 150-nt synthetic RNA oligoribonucleotide with a single Ψ
site at position 43 (Experimental Procedures). Examining the Ψ-ratio revealed a single
strong peak precisely one base downstream of the modified site, as expected (Figure 1C). To
assess whether Ψ-seq could quantify Ψ’s stoichiometry, we mixed the modified
oligoribonucleotide with a non-modified counterpart, at ratios ranging from 0% to 100%.
There was excellent quantitative agreement between the known stoichiometry and its Ψ-seq
quantification (Pearson r=0.98, Figure 1C–D). Thus, Ψ-seq can identify Ψ sites and quantify
their relative stoichiometry by the Ψ-ratio. However, the Ψ-ratio does not capture the
absolute stoichiometry: even with a fully pseudouridylated probe only 43% of the reads
terminated at the Ψ site, suggesting partial efficiency of either CMC modification or Ψ-CMC
mediated reverse transcription termination. Finally, down-sampling of the spike-in data
showed that Ψ-ratios depended on sequencing depth: variability of Ψ-ratio estimates
decreased with increased depth and with increased Ψ stoichiometry (Figure S1).
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Ψ-seq of log-phase yeast reliably detects known Ψ sites
We applied Ψ-seq to RNA isolated from yeast at log-phase, and found excellent overlap
(Figure 1E) between the experimentally determined Ψ sites and the 45 known sites within
the three rRNA subunits (18S, 25S and 5.8S) (Ofengand, 2002). We had a very high
discriminatory power between a gold standard of positive (known) and negative (all
remaining) sites in rRNA, thresholding on either the Ψ-ratio (area under the receiver-
operator curve (AUC) =0.942), Ψ-fc (AUC=0.955), or their logistic combination
(AUC=0.967) (Figure 1F). Based on this analysis of known sites, we called a site as
pseudouridylated in a transcriptome-wide analysis (Experimental Procedures) using the
‘pseudouridine detection thresholds’ of Ψ-fc >3 (8 fold-enrichment) and Ψ-ratio >0.1. These
thresholds favor precision over sensitivity: 31/32 rRNA positions called by these criteria are
known sites (precision=97%), but 14/45 known sites are not called (sensitivity=69%). Thus,
all subsequent analyses may underestimate the number of true Ψ sites. Further supporting
call accuracy, 88/94 called sites (94%) in log phase yeast were immediately preceded by a
‘U’ (Figure 1G), and 5/6 remaining sites were one nucleotide away from the 88 called sites,
and thus read accumulation at these five sites is likely due to ‘stuttered’ termination of
reverse transcription (Bakin and Ofengand, 1998). Down-sampling of a deeply sequenced
sample shows dependency of site detection on sequencing depth and transcript expression
(Figure S2).
Ψ-seq of deletion mutants associates Ψ sites and their cognate PUSs
Applying Ψ-seq to RNA from yeast at mid-log, we called both known target sites and ones
not previously reported. To validate these putative sites, we reasoned that Ψ-seq in deletion
mutants of either PUSs or relevant snoRNAs would allow us to match sites to their cognate
enzymes, and increase our confidence in their accuracy. Indeed, Ψ-seq of deletion strains for
snR34 or snR189 found specific reduction at the two known positions targeted by each 18S
and 25S rRNA, whereas other sites remained correlated, readily identifying the cognate
target sites (Figure 2A).
Next, we applied Ψ-seq to deletion strains of each of four additional snoRNAs and eight
non-essential PUSs (Pus1, Pus2, Pus4, Pus5, Pus6, Pus7, Pus9, Deg1) (Figure 2B). Across
the 14 experiments, we identified 291 sites with median Ψ-fc >3 and median Ψ-ratio >0.1,
with 55/291 dependant on a single PUS by stringent criteria (Experimental Procedures,
Figure 2B). Ψ-seq of a Cbf5 conditional knockdown detected 67 Cbf5-dependent sites
(Experimental Procedures, Figure 2C).
Overall, we called 328 unique sites across these experiments (‘Pan Ψ collection’, Table S1),
108 of which were associated with one or more PUS and/or snoRNA (‘PUS-dependent Ψ
collection’). These sites spanned various classes of coding and non-coding RNA (Figure 2D,
2E). While subsequent analysis focuses on the higher-confidence, PUS-dependent
collection, many of the additional sites in the Pan Ψ collection are likely truly
pseudouridylated, but did not pass our stringent criteria; Alternatively, Ψ at some sites may
be catalyzed by more than one PUS, and thus fail to pass our stringent thresholds.
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Unbiased analysis of Ψ in rRNA, tRNA and snRNA
The PUS-dependent collection associated the overwhelming majority of known sites with
their correct PUS and snRNA dependencies, demonstrating the power of our approach. For
rRNA, 24/24 Cbf5-dependent sites are known targets of pseudouridylation, 8/9 associations
between snoRNAs and rRNA sites are known, as is the identified Pus5-mediated Ψ site in
mitochondrial 21S rRNA. One unknown, snR3-dependent site at position 2140 on 25S
rRNA will require further verification.
For tRNA, many known sites and their associated modifiers were identified, including Pus1-
mediated Ψ sites at positions 26–28 in several tRNAs, Pus7-dependent sites at position 13 of
glutamate tRNA, Pus9-dependent site in mitochondrial aspartate tRNA at position 32, and
Deg1-dependent sites at positions 37–38 in several tRNAs.
For snRNAs, we correctly identified all three previously identified sites in positions 35, 42
and 44 of U2 snRNA, and their dependence on Pus7, Cbf5 and Pus1, respectively. We also
detected the known site in U5 snRNA, and found it depends on Cbf5 (not previously
known).
Cbf5-dependent pseudouridylation in the 5′ guiding sequence of C/D box and H/ACA box
snoRNAs
To our knowledge, no Ψ site within snoRNA has been mapped to date, although Ψ content
within snoRNAs has been reported (Ni et al., 1997). The PUS-dependent Ψ collection had
six Cbf5-dependent snoRNA sites, 4 within C/D box snoRNAs and 2 in H/ACA box
snoRNAs. All 4 Cbf5-dependent sites in C/D box snoRNAs occurred in the 5′ terminus of
the snoRNA guiding sequence (Figure 3A, arrows). Pseudouridylation within this stretch is
conserved, as 6/9 Ψ sites in C/D box snoRNAs identified in human HEK293 cells (below)
are present within the short complementarity stretch of the snoRNA (Figure 3B). The Pan-Ψ
collection had 21 additional sites in H/ACA box snoRNAs: 10/21 in H/ACA box snoRNAs
with resolved hairpin (targeting) structures (Piekna-Przybylska et al., 2007), and 4/10 in the
5′ arm of the guiding sequence (none in the 3′ arm) (Figure 3C, arrows). We cannot
conclusively determine that these sites are Cbf5 dependent, since our detection power is
limited by the dramatic decrease in the levels of H/ACA box snoRNAs upon Cbf5
knockdown (Figure 3D), consistent with their stabilization via Cbf5 binding (Lafontaine et
al., 1998).
PUS-dependent Ψ sites in mRNAs at consensus sequences of cognate PUSs
Whereas no Ψ sites have been previously reported in mRNAs, Ψ-seq uncovered 41 PUS-
dependent sites in 41 mRNAs from yeast grown in mid-log phase. These include 34 Cbf5-
dependent sites, occurring at a variety of consensus sites, suggesting they may be mediated
by snoRNAs (below). Conversely, the 7 sites dependent on one of three non-essential PUSs
(Pus1, Pus4, Pus7), were typically associated with distinct consensus motifs: each of the 3
PUS4 dependent sites (in TEF2, MPM1, and ICL2) resided in a ‘RRUUCNA’ motif
(underlined U indicates the putative site), perfectly conforming to the known Pus4
‘GGUUCRA’ target sequence at position 55 of tRNA (Becker et al., 1997a); one PUS7-
dependent site in SPI1 was at a ‘UGUAA’ sequence, matching a ‘UNUAR’ consensus at
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Pus7 targets in tRNAs and in snRNAs (Behm-Ansmant et al., 2003; Decatur and Schnare,
2008) (and which we expand to ‘UGUAR’, below). With one exception, all Pus1 dependent
targets (in coding and non-coding genes) were preceded by an A, suggesting partial, but
lesser, sequence specificity. We did not observe any positional bias along coding sequences
(we only analyzed coding regions due to very short UTRs, limited annotation, and very few
Ψ sites in non-coding regions).
Cbf5-dependent Ψ sites in mRNAs and snoRNAs are likely snoRNA-guided
As the substrate specificity of Cbf5 is typically mediated through H/ACA box snoRNAs, we
hypothesized that the Cbf5-dependent sites in mRNAs were also snoRNA-guided. To test
this hypothesis, we compiled all known H/ACA box targeting arms and used a
thermodynamics-based method to assess the folding energy of each snoRNA against each
Cbf5-dependent Ψ site (Experimental Procedures). For each site, we identified the
snoRNA with the minimal predicted free energy (strongest co-folding) and calculated a Z
score for this association with respect to the predicted energies of association with all
remaining snoRNAs. Validating our approach, we found that known rRNA Ψ sites had
significantly stronger associations with H/ACA box snoRNAs than their shuffled
counterparts (Figure 3E).
Overall, Cbf5-dependent sites in mRNAs and snoRNAs had stronger associations with
targeting regions in H/ACA box snoRNAs than shuffled controls. This was partly evident
when comparing the two distributions (one sided Wilcoxon test, P=0.07, Figure 3E), and
most prominent for outliers (e.g., Figure 3F). For example, 23.2% of Cbf5-dependent sites in
mRNA and snoRNAs were associated with an H/ACA box with a Z score < −3.5, compared
to 11% for shuffled controls (χ2 test, P=5.8×10−8).
Dynamic Pus7-mediated pseudouridylation of mRNAs in heat shock may affect RNA levels
The PUS-dependent sites in mRNAs raised the possibility that they may be differentially
regulated under different conditions. To test this hypothesis, we compared Ψ-seq profiles in
log phase to those from yeast in growth saturation, cold shock, and heat shock. While only a
few positions selectively acquired in Ψ stationary phase or cold shock (Figure 4A), 265
putative Ψ sites were induced in heat shock (45°C) vs. log growth (30°C) in three
independent replicates (Figure 4A, Table S2). A few are in key heat shock induced genes
(e.g., HSP60, HSP104, MDJ1, SSA4; Figure 4B), but most are in transcripts expressed at
similar levels in heat shock and vegetative growth (Figure 4B), suggesting that they are
differentially pseudouridylated, rather than differentially expressed.
The majority of heat shock acquired sites (159/265, 60%) occur in a perfect ‘UGUAR’ Pus7
consensus sequence (R=G>A) (Figure 4C), suggesting that the pseudouridylation program
in heat shock is induced through Pus7. To test this hypothesis, we applied Ψ-seq to a Δpus7
strain in normal and heat shock conditions. Ψ sites harboring the Pus7 consensus were
reduced to background levels in the Δpus7 strain in both conditions (Figure 4D–E). Thus,
there is a widespread, Pus7-mediated, pseudouridylation program in heat shock, that may
encompass the previously identified position in U2 snRNA induced in heat shock (Wu et al.,
2011). Importantly, the distribution of Ψ-ratios in UGUAR sites in mRNA in heat shock is
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comparable to that of rRNA sites, suggesting that mRNA sites are pseudouridylated to high
stoichiometries (Figure S3A).
To explore the role of pseudouridylation, we compared the expression level (from RNA-seq)
between WT and Δpus7 yeast for 142 genes that harbor Pus7-dependent Ψ sites in heat
shock vs. the remaining, non-pseudouridylated genes (Figure 4F), in either heat shock or
normal conditions. In heat shock, pseudouridylated genes were expressed at ~25% higher
levels in WT strains than in Δpus7 strains, whereas non-pseudouridylated genes were
expressed at roughly equal levels in the two strains. In contrast, the two sets were
comparably expressed in WT and Δpus7 at 30°C. These differences in expression only in
pseudouridylated genes and only in heat shock suggest that pseudouridylation may
contribute to RNA stability. We did not, however, find a significant correlation between the
Ψ-ratio and the change in expression. Future studies of RNA half-life with methods
compatible with dynamic responses (Miller et al., 2011) will help study this phenomenon.
We explored the basis for Pus7′s increased activity in heat shock. Surprisingly, both Pus7
RNA and protein levels are reduced in heat shock (Figure 4G), but there are significant
differences in Pus7 localization: it is predominantly nuclear in 30°C, and primarily
cytoplasmic in heat shock (Figure 4H, 4I). Thus, Pus7 localization may underlie its
enhanced repertoire of substrates in heat shock. Supporting a functional role for Pus7 in heat
shock, Δpus7 yeast show growth defects after heat shock in comparison to WT (data not
shown), consistent with a previous report on their increased heat sensitivity (Sinha et al.,
2008).
Finally, we explored factors that may govern modification specificity. First, in the most
highly expressed genes, ~30% of UGUAG containing loci are modified, suggesting that the
consensus plays a decisive role (Figure S3B). Furthermore, even among the remaining 70%,
Ψ-ratios were increased in WT compared to Δpus7 in heat shock (but not at 30°C),
suggesting that many are, in fact, modified (Figure S3C). Nonetheless, TGTAR loci called
as modified were more likely to have an A/T at position +3, and a pyrimidine at position −4
(Figure S3D), suggesting that features beyond UGUAG also contribute to specificity.
Pseudouridylation profiles and mechanisms are conserved in human
To assess the extent of similarity between yeast and human pseudouridylation, we
performed Ψ-seq in HEK293 cells and fibroblasts (below). Applying the same thresholds,
we identified 396 putative Ψ sites (Table S3): 353 sites in mRNA and 43 sites in non-coding
RNAs (excluding rRNA). We found no functional enrichments in pseudouridylated genes
compared to an expression-matched control set and the sites were relatively uniformly
distributed across coding and untranslated regions (data not shown).
To associate PUSs to Ψ sites, we examined the sequences surrounding the sites. The most
enriched motif (Figure 5A, 70/396 sites), had a GUUC core and was generally characterized
by ‘RGUUCNANYCY’, perfectly corresponding to the known Pus4-modified site in
tRNAs, and extending the Pus4 consensus in yeast. Another enriched motif (Figure 5B),
‘UGUAG’, present in 8 sites, is consistent with a mammalian Pus7 homolog. Thus,
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homologs of the same two site-specific PUSs are likely active on yeast and mammalian
mRNA.
The similarity between Ψ sites in yeast and mammals suggested that the other 318 sites,
lacking a Pus4 or Pus7 consensus, may be modified by DKC1/Dyskerin, the mammalian
Cbf5 ortholog. To test this hypothesis, we used siRNAs to knock down DKC1 to ~8% of
WT RNA levels (data not shown), and found significant reduction (Figure 5C,
Experimental Procedures) in Ψ levels at 58/396 sites. The 58 DKC1-dependent sites had
significant complementarity to human snoRNAs (P<0.03, one sided K-S test vs. randomly
shuffled sequences using the same approach as in yeast). In contrast, Ψ levels were only
negligibly reduced upon knockdown in sites containing either a Pus4 or a Pus7 motif (Figure
5C). Many of the 262 sites that we had neither associated with DKC1 (by knockdown) nor
with Pus4 nor with Pus7 (by motif) had borderline effects from DKC1 knockdown, and may
thus be substrates missed by our stringent criteria.
The number of Ψ sites we report in human is likely a very conservative lower bound, due to
our stringent thresholds and requirement for very deep coverage, in particular at moderately
or lowly expressed transcripts (Figure S2A). Indeed, when slightly relaxing the criteria of
calling a Ψ site (minimal Ψ-ratio: 0.05, minimal Ψ-fc: 2.5), we identified 176 additional
Dyskerin-dependent sites. Only two sites are substantially increased upon Dyskerin/Cbf5
knockdown, suggesting a <1% false detection rate. Thus, as in yeast, mammalian mRNAs
have a rich landscape of Ψ sites, mediated by at least three orthologous PUSs.
rRNA Ψ levels are conserved from yeast to human
We next examined whether the extent (stoichiometry) of pseudouridylation was conserved
across species, focusing on rRNA positions that are largely conserved throughout eukaryotes
and substantially covered in our data. To enhance our comparisons, we also collected Ψ-seq
data from log-phase Candida albicans and from mouse bone marrow derived dendritic cells.
We found that Ψ levels were quantitatively conserved between S. cerevisiae and C. albicans
(R=0.78, Figure 5D), between human and mouse (R=0.78, Figure 5E), and even between
yeast and human (R=0.67, Figure 5F), suggesting that both the presence and relative
abundance of rRNA Ψ sites are under strong purifying selection.
Reduced rRNA Ψ levels in cells from dyskeratosis congenita patients
It has been hypothesized that aberrant rRNA pseudouridylation could underlie X-linked
dyskeratosis congenita, caused by mutations in DKC1/dyskerin, but the extent to which it is
altered remains controversial (Wong and Collins, 2006), (Bellodi et al., 2013), (Gu et al.,
2009; Mochizuki et al., 2004).
Applying Ψ-seq to fibroblasts derived from 7 and 11 year old patients harboring two distinct
mutations (del37L and A386T, respectively) and to cells from age-matched controls, we
found subtle – yet significant – decreases in rRNA pseudouridylation among patients
(Figure 5G), and Ψ-seq profiles further group in unsupervised analysis by disease and not by
age (Figure S4A). The subtle effect, on average a reduction of 10% in Ψ-ratio per site, likely
explains why these were difficult to observe with less sensitive techniques. As a reference,
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rRNA pseudouridylation per site is reduced on average a dramatic 55% upon DKC1
knockdown (Figure 5H).
Decreased pseudouridylation in telomerase RNA component (TERC) in dyskeratosis
congenita cells
Dyskeratosis congenita can also be caused by mutations in the ncRNA telomerase
component, TERC (Hoareau-Aveilla et al., 2008; Trahan and Dragon, 2009). TERC is
bound and stabilized by DKC1, but is destabilized in dyskeratosis congenita (Ashbridge et
al., 2009). Our findings of Ψ sites within snoRNAs (Figure 3) prompted us to examine
whether TERC, which harbors an H/ACA box domain, might be pseudouridylated as well,
in a DKC1-dependent manner. While TERC sites were not called in Hek293 cells, the read
distribution across TERC revealed a putative Ψ site at position 307 (Figure S4B). This site
was not called due to low read counts in the lowly-expressed TERC. TERC expression was
even lower in the fibroblasts (Patients FPKM: 0.15 and 0.28; controls: 2.8 and 0.8),
precluding any analysis.
To detect and quantify Ψ sites in TERC we first enriched it in RNA from fibroblasts of
patients and age-matched controls using hybrid capture with RNA Antisense Purification
(RAP) (Engreitz et al., 2014) (Experimental Procedures). This resulted in ~750 fold
enrichment in the fraction of reads in the CMC-treated samples aligning to TERC compared
to poly(A) selected RNA. Ψ-seq of the hybrid-captured RNA confirmed substantial
pseudouridylation of position 307 (Figure 5I), a highly conserved uridine (Figure 5K) in a
region essential for telomerase activity and TERT binding (Chen et al., 2002), and showed
that it is modified at significantly higher levels in the control sample (Ψ-ratio=0.47) than in
the patient sample (Ψ-ratio=0.33) (Figure 5J, χ2 test, P=0.006). A similar reduction was
observed when comparing samples from the 11 year old patient to the age matched control
(χ2 test, P=0.01; Figure S4C). Another putative Ψ site was found at position 179 albeit at
substantially lower levels (Ψ-ratio=0.11). This confirms two of the six previously proposed
Ψ positions in TERCs (we do not find evidence for the others) (Kim et al., 2010), suggests
that TERC pseudouridylation may be compromised in dyskeratosis congenita, and provides
a general way to quantify Ψ in lowly expressed genes.
Discussion
Ψ-seq profiles Ψ in an unbiased, quantitative, transcriptome wide manner at single-
nucleotide resolution. It discovered pseudouridines in S. cerevisiae and human snoRNAs
and mRNA, catalyzed by both snoRNA-dependent PUSs and site-specific PUSs guided by
consensus sequences. We identified a dynamic program induced in yeast heat shock, where
Ψ sites accumulate at hundreds of mRNAs, possibly affecting RNA levels. Ψ-seq allows us
to compare Ψ stoichiometries across rRNA positions, finding that these are highly
conserved, but reduced in cells from dyskeratosis congenita patients. Although we cannot
exclude the possibility of some false positives, our stringent controls and excellent
correspondence to prior knowledge suggest that their rate is low. The roles of PUSs and Ψ
are likely more complex than previously assumed, and our genome-wide method can help
study this.
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Ψ-seq can be further enhanced in several ways. First, to accurately estimate Ψ levels in
lowly expressed transcripts it can be combined with hybrid capture, as demonstrated for
TERC, or with new methods to pre-enrich for pseudouridylated RNA. Second, Ψ-seq cannot
monitor Ψ levels at 3′ transcript ends, as it relies on reverse transcription termination. To
help probe Ψ in short RNA, we could couple Ψ-seq with alternative ligation protocols.
Finally, Ψ-seq is theoretically limited in identifying two closely proximal pseudouridines, as
reverse transcription is expected to always terminate at the downstream – and never at the
upstream - site. In practice, however, this does not appear to be a major limitation: for
example, we detect adjacent positions in rRNA (e.g., 25S:1052 and 1056) or in U2 snRNA
(positions 42 and 44). This is likely due to a incomplete stoichiometry, incomplete CMC-
labeling of Ψ bases and/or imperfect efficiency ofRT-stopping at CMC-treated sites, though
Ψ quantification at such adjacent sites may nonetheless be impacted.
PUS substrate specificity
Site-specific, non-essential PUSs in S. cerevisiae were previously thought to modify only
one (or a few) residues, by recognizing secondary or tertiary structures in a specific RNA
substrate (Becker et al., 1997b). Our results demonstrate that such PUSs have a dramatically
larger substrate repertoire than previously assumed, and suggest that many PUS-mediated
modifications are guided in part by primary sequence features in their substrates (Figure
6A).
This is conserved from yeast to mammals, where the predominant consensus is identical to
that in yeast Pus4, suggesting that Ψ is mediated by TruB1/TruB2, the mammalian orthologs
(Zucchini et al., 2003). There are at least 23 putative PUSs in human (Hunter et al., 2011),
and one cannot fully rule out the possibility of additional PUSs in yeast; perturbation
experiments will help elucidate their targets, as well as resolve possible functional
redundancies (Grosshans et al., 2001).
We also find evidence for mRNAs pseudouridylation via snoRNA-dependent PUSs. A more
elaborate repertoire of snoRNA substrates, potentially mediated through imperfect
complementarities, has previously been hypothesized (Wu et al., 2011), based on the single
finding that heat-shock/nutrient-deprivation induced Ψ at position 93 in U2 snRNA is
guided through imperfect pairing with snR81 (Wu et al., 2011).
Pus7-pseudouridylation program in heat shock
The Pus7-dependent induction of pseudouridylation during heat shock is an attractive
system for further studies of Ψ function. The specificity of the modified site to heat shock
(despite lower levels of Pus7 than in other conditions) and the similarity of distribution of Ψ-
ratios to rRNA could be consistent with a regulated system, but further functional studies are
warranted. This program may be mediated through Pus7 localization in the cytoplasm in
heat shock (Figure 6B). Since RNA levels of pseudouridylated targets are higher in WT
compared to Δpus7, it is tempting to speculate that Ψ may serve to stabilize transcript
structure in heat shock. Alternatively, Ψ could target specific mRNAs to heat shock induced
stress granules in a similar manner to m6A destabilization of RNA by directing it to P
bodies (Wang et al., 2014). Such responses could help cells to better withstand heat shock,
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consistent with the increased heat sensitivity of the Pus7 deletion strain in S. cerevisiae
(Sinha et al., 2008). Pseudouridylation of a stop codon was previously shown to suppress
translation termination (Karijolich and Yu, 2011), suggesting that Ψ might modify the
genetic code. We found only a single putative site in a stop codon in HEK293 cells and none
in yeast; greater depth may revise these predictions.
Interestingly, Ψ levels at position 50 in 5S rRNA, also catalyzed by Pus7, also increase in
heat shock, suggesting that it is not fully modified during exponential growth, and that its
pseudouridylation might confer an advantage during heat shock. These data challenge the
notion that rRNA modifications are constant across growth conditions, and suggest that the
stoichiometry of rRNA modification may also change in response to external stimuli.
Pseudouridylation in dyskeratosis congenita
Pseudouridine is particularly important in dyskeratosis congenita, caused by mutations in the
Cbf5 ortholog DKC1/dyskerin. Our results contribute two findings. First, we observed a
subtle, yet significant, quantitative difference in Ψ levels in patient derived samples,
compared to age-matched controls, which were not previously observed in some studies
(Wong and Collins, 2006), but suggested in others (Bellodi et al., 2013), possibly due to less
sensitive methods. Second, we detect two putative Ψ sites in TERC, one of which at very
high levels and at highly conserved position 307 within the essential P6.1 hairpin (Chen et
al., 2002). A Ψ site was previously proposed at that position, and shown to significantly
increase stability of the loop structure in vitro (Kim et al., 2010). Our findings may unify the
two roles attributed to dyskerin – of stabilizing TERC and of pseudouridylating RNA – and
suggest that dyskerin may both bind to and pseudouridylate TERC, and that both processes,
perhaps in a mechanistically coupled manner, may be disrupted in the disease.
Pseudouridylation in ncRNAs at sites of inter or intra-molecular interactions
It has previously been noted that Ψ sites in rRNA and snRNAs tend to occur in ‘important’
regions that directly interact with other molecules. In U1, U2, U4 and U6 snRNAs, for
example, Ψ sites occur at or close to a site that basepairs with intronic RNA to facilitate
RNA splicing (Charette and Gray, 2000). In rRNA there is a high density of conserved Ψ
sites at the peptidyl-transferase center and at the decoding center of the 25S rRNA subunit,
which interacts with mRNA and with the tRNA stem-loop (Bakin et al., 1994; Bakin and
Ofengand, 1993; Lane et al., 1992). Our study extends these observations to snoRNAs,
where we find Ψ sites within both C/D and H/ACA box snoRNAs, at positions involved in
base-pairing with target sites. The highly conserved Ψ site in TERC is also in a region
crucial for telomerase activity, involved in binding to TERT (Chen et al., 2002).
Ψ may also play a role in intramolecular interactions. For example, a Pus1 dependent Ψ site
at position 273 in NME1, the RNA component of yeast RNAse MRP, is in a stem structure
in the P2 region (Esakova and Krasilnikov, 2010; Esakova et al., 2013; Reilly and Schmitt,
1995), and a site in the helix 2 loop of U3, is involved in pre-ribosomal rRNA cleavage.
Mapping Ψ sites in ncRNA molecules may help delineate sites involved in inter and
intramolecular interactions.
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Our quantitative and high-resolution methodology coupled with genetic perturbations
yielded unbiased, transcriptome-wide maps of Ψ across different RNA species, identified
consensus sequences recognized by the PUS enzymes, and established pseudouridine as a
ubiquitous and dynamic modification of eukaryotic mRNA. Further studies will leverage
this method and finding to elucidate Ψ’s function in the RNA life cycle, especially of
mRNA.
Experimental Procedures
Yeast growth conditions
Unless otherwise noted, yeast were grown in YPD supplemented with .27mM uridine, heat
shock was performed at 45°C for the designated time points, and collected as described in
the Extended Experimental Procedures. Growth curves were measured in 96 well plates
using a Tekan plate reader. Deletion strains are listed in the Extended Experimental
Procedures.
Ψ-seq
Ψ-seq was performed on PolyA+ RNA treated with. CMC essentially as previously
described (Bakin and Ofengand, 1993; Bakin and Ofengand, 1998), and detailed in
Extended Experimental Procedures. Input controls were handled identically in all steps
but without CMC treatment. Following the procedure, RNA-Seq libraries were prepared by
an RNA ligation method as detailed in the Extended Experimental Procedures and
sequenced on Illumina HiSeq 2500 with 30bp paired end reads.
Detection of Ψ sites
Reads were mapped to the yeast genome (sacCer3) using Bowtie, or to the human (hg19)
genome using Tophat,, with parameters and scripts as described in the Extended
Experimental Procedures. For rRNA and snRNA sites, we aligned reads against specific
database of these two classes. Mouse reads were aligned to mouse rRNA from Refseq. C.
albicans reads were aligned to the C. albicans genome (SC5314 version A21). Ψ sites were
identified by first calculating a Ψ-ratio for each treated or input sample, followed by Ψ-fold
change (log2 fold changes of Ψ ratios in the treated versus non-treated samples). Sites were
filtered by parameters listed in the Extended Experimental Procedures. For all unique
sites passing the filters in at least one sample, we calculated a Ψ-ratio and Ψ-fc in each
sample and considered all sites whose median Ψ-ratio and median Ψ-fc exceeded 0.1 and 3,
respectively (unless otherwise noted). We demanded that each 21 nt sequence surrounding
the putative Ψ site be unique, and also filtered sites in positions other than immediately
following ‘U’. To compare orthologous rRNA sites across species, we used ‘needle’ (Rice et
al., 2000) for pairwise alignments of rRNAs with lift over of known Ψ sites (Machnicka et
al., 2013) from human to mouse and from S. cerevisiae to C. albicans. For further details see
Extended Experimental Procedures.
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Synthetic spike-ins
We in vitro transcribed an RNA bait containing only a single uridine (Extended
Experimental Procedures), and mixed pseudouridylated and non-pseudouridylated RNA at
indicated ratios.
PUS dependent sites
We identified differentially pseudouridylated sites across deletion strains of non-essential
PUSs and snoRNAs we tested both the number of reads starting and overlapping at each
putatively identified position between a given sample and the background of all samples,
with a procedure based on a χ2 test detailed in the Extended Experimental Procedures,
and similar procedures for heat-shock, Pus7-dependent sites, Cbf5-dependent sites, and
CDK1-dependent sites.
Motif analysis
We used position specific scoring matrices (PSSMs) defined by 21 bp sequences spanning
the identified Ψ sites, visualized using SeqLogo in R, and displaying only regions with non-
uniform sequence composition.
Prediction of association between Cbf5-dependent target sites and snoRNAs
We assessed the hybridization potential between Cbf5-dependent target sites and H/ACA
box snoRNAs by calculating free energies of concatenated upstream and downstream
complementary arms (Piekna-Przybylska et al., 2007), separated by a constant hairpin
sequence, folded against a 20-nt region surrounding each CBF5 dependent site using
RNAcofold (Gruber et al., 2008), with parameters and constraints described in the Extended
Experimental Procedures. We shuffled each 20-nt region 15 times (maintaining a center
U) as controls.
Pus7 localization
Pus7 localization was measured by microscopy of S. cerevisiae encoding GFP-tagged Pus7
grown at 45°C using a Nikon Eclipse Ti with oil immersion at 100X magnification. ImageJ
was used to quantitate GFP intensity with DAPI staining to define nuclear boundaries, as
detailed in the Extended Experimental Procedures.
Bone marrow derived dendritic cells
Cells were prepared as previously described (Amit et al., 2009). All experiments were
performed in compliance with the institutional guidelines and were reviewed and approved
by the Institutional Animal Use and Care Committee (IAUCC) of MIT (Protocol
0612-058-15).
DKC1 knockdown
Human HEK293 cells were plated in 6-well plates at 20% confluence. siRNAs targeting
DKC1 (catalog numbers: s4111 and s4112) were transfected using Lipofectamine
RNAiMAX (Life Technologies) following the manufacturer’s protocols, with boosts at 48
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and 96 hours; As negative controls, we used Ambion® In Vivo Negative Control #1 siRNA
(catalog number: 4457287). Cells were harvested at 144 hours.
Samples from dyskeratosis congenita patients
Fibroblasts were obtained from Coriell [(GM01774 (del37L, 7 years), AG04646 (A386T, 11
years), GM00409 - (healthy 7 year old), GM01864 - (healthy 11 year old)].
RAP-RNA enrichment of TERC
We performed RAP on intact isolated total RNA as previously described for RAP-
RNA[AMT] (Engreitz et al., 2014).
Supplementary Material
Refer to Web version on PubMed Central for supplementary material.
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Highlights
• Ψ-seq for high resolution, transcriptome-wide profiling of pseudouridine
• Many novel sites in mRNA; dynamically regulated in heat shock
• Sites depend on conserved cognate pseudouridine synthases in yeast and human
• Reduced rRNA and TERC pseudouridine in dyskeratosis congenita patients
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Figure 1. Ψ-seq quantitatively measured transcriptome-wide pseuodouridylation profiles
(A) Ψ-seq procedure. Poly(A) selected RNA is treated with CMC, which covalently binds to
U and residues, and, to limited extent, G (Ho and Gilham, 1971; Metz and Brown, 1969a, b),
followed by incubation at alkaline pH, leading to hydrolysis of U-CMC adducts, which are
less stable than Ψ-CMC counterparts. RNA is next fragmented to a size range of 80–150 nt,
followed by adapter ligation to the 3′ end. Reverse transcription is primed off of the adapter,
expected to lead to premature termination one base pair immediately downstream of
pseudouridylated sites. A second adapter is ligated to the 3′ end of the cDNA and libraries
are amplified and sequenced in paired end mode. (B) Scoring modified sites. Ψ-ratio (red,
top) between reads terminating at a site and reads overlapping it, and Ψ-fc (blue, bottom),
the fold change in Ψ-ratio in the CMC-treated sample over non-treated control. (C)
Validation with a synthetic spike in. Ψ-fc (Y axis) at each position (X axis) across a
synthetic spike-in harboring one pseudouridylated site at varying stoichiometries (color
legend) at the indicated position (arrow). (D) Ψ-seq quantifies relative stoichiometry. Scatter
plot comparing Ψ-ratios (Y axis) at the pseudouridylated site in the spike-in with
pseudouridine stoichiometries (X axis). The Pearson correlation coefficient (r) and
associated P value are denoted. (E) Ψ-seq detects known Ψ sites in rRNA. Ψ-fc values (Y
axis, dark blue) at each position (X axis) in 18S rRNA, overlaid with all known Ψ sites in
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this subunit (grey vertical lines). (F) ROC curves for different metrics (color legend) for
calling putative Ψ sites. Each classifier was trained based on Ψ-seq data from human rRNA,
and tested on their performance in yeast rRNA. (G) Nucleotide distribution across all sites
passing our detection thresholds in a sample in mid-log yeast. See also Figure S1.
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Figure 2. Identification of PUS-dependent Ψ sites in yeast
(A) Ψ-seq correctly distinguishes targets of snoRNAs. A comparison of Ψ-fc scores across
all known Ψ sites in three rRNAs (18S, 28S, 5.8S) measured in yeast strains in which either
H/ACA box snR34 (X axis) or snR189 (Y axis) were deleted. snR34 is known to target
positions 2880 and 2886 in 25S rRNA (red), snR189 targets positions 2735 in 25S and 466
in 18S rRNA (purple), all detected as outliers in these experiments. (B) Ψ-seq associated
modified bases with their cognate PUS and snoRNAs. Heatmap depicting Ψ-ratios (Z scores
per row, color bar) across all sites (rows, gene and position labeled on left) in the PUS-
dependent collection that are dependent on a snoRNA or a non-essential site-specific PUS
(columns). For tRNAs, the labeled position is with respect to a multiple alignment of tRNAs
with manual correction at two sites, to allow comparison between sites. A check mark
indicates that a site was both previously known to be pseudouridylated and that its catalysis
was known to be mediated through the enzyme or snoRNA with the minimal Z score in the
figure. (C) Ψ-seq identifies Cbf5-dependent Ψ sites. As in (B) for all sites (rows) dependent
on Cbf5. (D) Distribution of Ψ sites in different RNA classes, in the Pan-Ψ collection (left)
and PUS-dependent collection (right). CDS: mRNA coding sequence. (E) Ψ-ratios (Y axis)
across the snoRNA snR47 (left), the mRNA GLK1 (middle), and the mRNA SPI1 (right),
which depend on Cbf5, Pus1 and Pus7, respectively. Ψ-ratios are presented for CMC-treated
(black) and non-treated (red) samples. Called Ψ sites are marked in vertical thick grey lines,
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and their ‘absence’ position (in the relevant deletion strain) is marked by a dashed grey box.
See also Figure S2 and Table S1.
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Figure 3. Pseudouridylation in yeast snoRNAs
(A) Complementarity regions between three C/D box snoRNAs in yeast (black) and target
sites in rRNA (red). Red arrows: detected Ψ sites. (B) As in A, but in human. (C) As in A,
but for H/ACA box snoRNAs. (D) SnoRNAs expression in WT strains (X axis) compared to
Cbf5 knockdown strains (Y axis), showing decreased expression of H/ACA box snoRNA
(red), but not C/D box snoRNAs (orange) or snRNAs (dark red), upon knockdown. (E)
Cumulative distribution frequencies of minimal Z-score transformed free energies, predicted
by cofolding each putative CBF5-dependent (or shuffled) site against all known H/ACA box
targeting arms. Distributions are plotted separately for sites in the rRNA (green), all
remaining sites in mRNA and snRNAs (blue), and their corresponding shuffled versions
(yellow and red, respectively). (F) Predicted associations between three CBF5-dependent
sites (red) and top-scoring H/ACA box snoRNAs (black).
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Figure 4. Induction of Pus7-dependent sites in heat shock
(A) Bar plots of the number of differentially modified sites (Y axis), in each of three
conditions (X axis) relative to mid-log yeast. Sites are color-coded based on RNA class
(color legend). (B) Differential modification in heat shock is not merely due to changes in
expression levels. Expression levels in heat shock (X axis) or non-heat shock (Y axis)
conditions for all genes harboring heat-shock induced Ψ sites. (C) Sequence motif learned
across all Ψ sites induced in heat shock, is strongly enriched for the TGTAR Pus7 motif. (D)
Ψ-ratios (Y axis) in CMC-treated (black) and non-treated (red) samples in five genes
(columns) acquiring Ψ sites in heat shock. Ψ-ratios are shown in WT in 30° (top) and heat-
shock (45°, middle), and in heat-shock in Δpus7 (bottom). Called sites are depicted in
vertical grey bars in the samples in which they are called, and dashed grey boxes in the
remaining samples. (E) Box plots of Ψ-ratios in WT or Δpus7 strains, grown in heat shock
or 30°, for 159 heat-shock induced sites harboring a Pus7 consensus (left) and 106 sites
without the consensus (right). (F) Cumulative distribution plots of fold changes of
expression levels between WT and Δpus7 strains (X axis), comparing genes harboring a
Pus7-induced Ψ sites (blue) to genes lacking it (red). At 45° (left), genes harboring Ψ sites
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are expressed at higher levels in the WT strain than in Δpus7, whereas non-pseudouridylated
genes are present at similar levels. At 30° (right), these differences are marginal. P-value of
the Kolmogorov-Smirnov test is depicted. (G) Pus7 transcript (left; mean TMM-normalized
FPKM values from three replicates) and protein (right, data in four replicates from (Nagaraj
et al., 2012)) levels (Y axis) in heat shock and non-heat shock conditions. Error bars are
standard error of the mean.(H, I) Pus7 localization. Fluorescent microscopy images (H) and
quantification (I) during a heat shock time course show mostly nuclear localization at 30°C
(time 0 in H, and red in I), which is significantly reduced after heat shock (time 60 in H,
blue in I). P-value of a Mann-Whitney test is noted. See also Figure S3 and Table S2.
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Figure 5. Ψ-seq of human RNA highlights conserved features and disease-relevance
(A–B) Sequence motifs from 70 sites harboring a Pus4 associated GUUC core (A) and 13
sites harboring a Pus7 associated UGUA core (B), of 396 modified sites in HEK293 RNA.
(C) Difference in Ψ-ratios in DKC1 knockdown relative to control (Y axis) in HEK293
cells. Box plots from left to right: DKC1-dependent sites, sites harboring Pus4 (GUUC) or
Pus7 (UGUAR) associated motifs, and all remaining sites. (D–F) Correlation of
pseduoridylation stoichiometries in rRNA between homologous positions in S. cerevisiae
and C. albicans rRNA (D), human and mouse (E), and yeast and human (F). Positions are
color-coded based on rRNA subunit. (G) Distributions of Ψ-ratios across rRNA positions in
fibroblasts from dsykeratosis patients (grey) and age-matched controls (pink). Left panel: 7
year old patient; Right: 11 year old patient. (H) Ψ-ratios in rRNA positions in DKC1
knockdown (grey) or control (pink) in HEK293 cells. (I) TERC modification is affected by
DKC1 knockdown. Number of reads (top; indicative of RT termination) and Ψ-ratios
(bottom) at each site in the TERC transcript (X axis). Reads are shown in both CMC-treated
(black) and non-treated (red) samples; Ψ-ratios for the treated samples. The putative Ψ
position is highlighted in a grey vertical bar. (J) Ψ-ratios for position 307 in 7-yr old patient
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and age matched control; Error bars: standard error. (K) RNA secondary structure of the
CR4/CR5 region in TERC redrawn based on (Zhang et al., 2011). Red arrow: putative Ψ
site. See also Figure S4 and Table S3.
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Figure 6.
(A) mRNA pseudouridylation in eukaryotes is mediated by at least four conserved PUSs,
some site specific (Pus1, Pus4, Pus7) and others snoRNA mediated (yeast Cbf5/human
DKC1). (B) Pus7 may orchestrate the yeast mRNA pseudouridylation program in heat
shock. At 30°, Pus7 is primarily nuclear, and its localization into the cytoplasm upon heat
shock may induce mRNAs pseudouridylation.
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